Taxon-specific markers for the qualitative and quantitative detection of bacteria in human samples

Similar documents
Molecular pathology with desorption electrospray ionization (DESI) - where we are and where we're going

MALDI-TOF Mass Spectrometry: A New Rapid ID Method in Clinical Microbiology

Challenges in Rapid Evaporative Ionization of Breast Tissue: a Novel Method for Realtime MS Guided Margin Control During Breast Surgery

Data Independent MALDI Imaging HDMS E for Visualization and Identification of Lipids Directly from a Single Tissue Section

MALDI Imaging Drug Imaging Detlev Suckau Head of R&D MALDI Bruker Daltonik GmbH. December 19,

Supporting Information

OVERVIEW OF CURRENT IDENTIFICATION SYSTEMS AND DATABASES

Tandem MS in Microbiology. Chris Doern, PhD D(ABMM) UT Southwestern Medical Center Dallas, TX

Optimizing MALDI-TOF Use. Clinical Impact Laboratory Impact

Intrinsic and Extrinsic Parameters of Foods That Affect Microbial Growth

Biological Mass Spectrometry. April 30, 2014

Desorption Electrospray Ionization Coupled with Ultraviolet Photodissociation for Characterization of Phospholipid Isomers in Tissue Sections

Supplementary Information. Ionization Mass Spectrometry

The MALDI Biotyper An In Vitro Diagnostic System (IVD) for Identification of Bacteria and Yeasts with a Global Reach

LC/MS Method for Comprehensive Analysis of Plasma Lipids

INTRODUCTION TO MALDI IMAGING

[application note] DIRECT TISSUE IMAGING AND CHARACTERIZATION OF PHOSPHOLIPIDS USING A MALDI SYNAPT HDMS SYSTEM

Real time connection of Mass Spectrometry with Medicine and Surgery

SCIENCE CHINA Life Sciences

Supporting information

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Phospholipid characterization by a TQ-MS data based identification scheme

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Matrix Assisted Laser Desorption Ionization Time-of-flight Mass Spectrometry

Mass spectrometry imaging. What does MS imaging offer?

Chapter 9. Summary & conclusion

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain

LECTURE 3. Ionization Techniques for Mass Spectrometry

Mass-Spectrometric Analysis of Lipids (Lipidomics)

Electronic Supplementary Information. Analysis of Intact Bacteria Using Rapid Evaporative Ionisation Mass Spectrometry

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

Metabolomics: quantifying the phenotype

Choosing the metabolomics platform

MALDI-TOF mass spectrometry tools for microbial identification in archival document investigation

Utility of neurological smears for intrasurgical brain cancer diagnostics and tumour cell percentage by DESI-MS

Hiroya Hidaka *1), Masaki Takiwaki 2), Mine Yamashita 2), Shinya Otsuki 1), Kenji Kawasaki 3), Mitsutoshi Sugano 3) and Takayuki Honda 4)

LOCALISATION, IDENTIFICATION AND SEPARATION OF MOLECULES. Gilles Frache Materials Characterization Day October 14 th 2016

The use of mass spectrometry in lipidomics. Outlines

INTESTINAL MICROBIOTA EXAMPLES OF INDIVIDUAL ANALYSES

The study of phospholipids in single cells using an integrated microfluidic device

Ionization Methods. Neutral species Charged species. Removal/addition of electron(s) Removal/addition of proton(s)

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Supporting Information

Sequence Identification And Spatial Distribution of Rat Brain Tryptic Peptides Using MALDI Mass Spectrometric Imaging

NAS Workshop on the Industrialization of Biology

Components of a Mass Spectrometer

Supporting information for: Memory Efficient. Principal Component Analysis for the Dimensionality. Reduction of Large Mass Spectrometry Imaging

Discrimination of Human Astrocytoma Subtypes by Lipid Analysis Using Desorption Electrospray Ionization Imaging Mass Spectrometry

Introduction. This paper

MALDI Imaging Mass Spectrometry

Mongolia September 2012

Chapter 12: Mass Spectrometry: molecular weight of the sample

Rapid identification and resistance assessment: The future is mass spectrometry

Quadrupole and Ion Trap Mass Analysers and an introduction to Resolution

Mass Spectrometry based metabolomics

Analysis of Triglycerides in Cooking Oils Using MALDI-TOF Mass Spectrometry and Principal Component Analysis

The Food and Drug Administration (FDA) is providing a detailed list of supplemental duodenoscope reprocessing measures that emerged from an agency-led

SelexION Technology for Lipid Analysis: Pushing the Boundaries of Lipidomics

Fundamentals of Soft Ionization and MS Instrumentation

Synthesis of Sequence-Controlled Acrylate Oligomers. via Consecutive RAFT Monomers Additions

Solving practical problems. Maria Kuhtinskaja

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry

An optical dosimeter for the selective detection of gaseous phosgene with ultra-low detection limit

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Metabolomic fingerprinting of serum samples by direct infusion mass spectrometry

MALDI-TOF. Introduction. Schematic and Theory of MALDI

Three Dimensional Mapping and Imaging of Neuropeptides and Lipids in Crustacean Brain

Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017

FATTY ACID PROFILING BY GAS CHROMATOGRAPHY FOR THE SHERLOCK MIS

Essential Lipidomics Experiments using the LTQ Orbitrap Hybrid Mass Spectrometer

MALDI-IMS (MATRIX-ASSISTED LASER DESORPTION/IONIZATION

Determination of Amantadine Residues in Chicken by LCMS-8040

Polymer Additive Analysis by EI and APCI

Ozonolysis of phospholipid double bonds during electrospray. ionization: a new tool for structure determination

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

Orderly increase in all the chemical structures of the cell. Cell multiplication. Increase in the number of the cells

Comparative study of MALDI-TOF MS and VITEK 2 in bacteria identification

Protein Analysis using Electrospray Ionization Mass Spectroscopy *

Supplementary Information

A STABLE DICATIONIC SALT IN REACTIVE DESI-MS IMAGING IN POSITIVE ION MODE TO ANALYZE BIOLOGICAL SAMPLES DRAGOS LOSTUN

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of beta-hemolytic streptococci

Small Scale Preparative Isolation of Corticosteroid Degradation Products Using Mass-Based Fraction Collection Application

The use of random projections for the analysis of mass spectrometry imaging data Palmer, Andrew; Bunch, Josephine; Styles, Iain

Relative Quantitation of Human Polymorphonuclear Leukocyte Cell Membrane GPEtn Lipids

Principles of Shotgun Lipidomics

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

Mass spectrometry-based intraoperative tissue identification in neurosurgery

Mass spectrometry Technologies in Lipid chemistry

Sample Preparation is Key

Structural Elucidation of N-glycans Originating From Ovarian Cancer Cells Using High-Vacuum MALDI Mass Spectrometry

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

Influence of Different Prebiotics and Probiotics on Selective Intestinal Pathogens

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Methods in Mass Spectrometry. Dr. Noam Tal Laboratory of Mass Spectrometry School of Chemistry, Tel Aviv University

MALDI-TOF MS: a new tool to rapidly assess antibiotic susceptibility

Foundations in Microbiology Seventh Edition

Shotgun metaproteomics of the human distal gut microbiota. Present by Lei Chen

Transcription:

Taxon-specific markers for the qualitative and quantitative detection of bacteria in human samples Nicole Strittmatter 1, James McKenzie 1, Adam Burke 1, Tony Rickards 2, Monica Rebec 2, Zoltan Takats 1 1 Section of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, UK 2 Department of Microbiology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK INTRODUCTION - DETECTION OF BACTERIA IN CLINICAL SAMPLES Microorganisms play an important role as human commensals and pathogens. To ensure the most effective treatment for bacterial infections, the causative agent has to be identified as precisely and as rapidly as possible. In routine clinical microbiology laboratories identification of a human pathogen is routinely based on isolating the pathogen of a clinical sample on solid culturing medium and subsequently obtaining a pathogen ID. Identification results can be traditionally obtained by observing phenotypic characteristics including colony morphology, carbon source utilization and enzymatic activity to define genera and species. A more recent and paradigm changing development in microbiological laboratories was the introduction of MALDI-TOF MS which enabled the identification of bacteria based on their cellular protein patterns. This methodology shortened the time-demand needed for identification by at least 24hrs. However, a purified culture is still needed for reliable identification results. Although direct-on sample applications were reported for urine and positive blood cultures, the protocols are of increasing complexity compared to the identification of pure cultures. Molecular genetic methods have the advantage of being independent of culture conditions and can potentially reduce the time-demand needed for identification, especially if the culturing step is completely eliminated. The sequencing of 16S rrna relies on the highly conserved nature of the 16S rrna which serves as a basis for current microbiological taxonomy. However, the method is rarely used in routine clinical microbiology settings due to the need for extensive sample preparation and associated costs.

Rapid evaporative ionization mass spectrometry (REIMS) was developed recently, specifically for real-time, in-vivo analysis of biological tissues in the surgical environment. The rationale for the development of the technique was to improve surgical margin assessment and identification of unknown tissues in the course of solid tumor resection interventions. Mass spectra obtained using REIMS feature mainly complex lipids of the cellular membranes and elicit high histological specificity in the case of mammalian tissues. It has been shown recently that this technology can be further applied to the analysis of microorganisms such as bacteria and fungi. 28 of the most important human bacterial pathogens and five Candida species have been shown to be distinguishable with >95% identification accuracy as compared to MALDI TOF MS. Furthermore, the technique was shown to distinguish seven different Escherichia coli strains independently of culture medium and culture age. Although microbial REIMS phospholipid profiles were shown to be highly specific and reproducible, detection and identification of microorganisms based on their full lipidomic profile in a complex human matrix such as sputum or tissues is most likely not feasible. Therefore, an alternative strategy is proposed here to allow for the detection of bacteria in complex matrices. This strategy involves the determination of complex lipid markers that are specific for certain taxa of bacteria (phylum- down to species-level). Subsequently, these socalled taxonomical markers are used to detect bacteria in human matrices. As a main example, the visualization of bacteria in colorectal tissue specimens is demonstrated. This approach is particularly interesting as using other techniques in this case would either lead to loss of spatial information (as with molecular methods) or loss of the untargeted nature (as in case of immunohistochemistry). MATERIALS AND METHODS Rapid Evaporative Ionization Mass Spectrometry. A REIMS spectral database was compiled of pure cultures of a variety of human pathogens and commensals. As taxonomical markers have to be present in a variety of different culture conditions, different culture ages, culture media, and different culturing atmospheres were included into the microbial database. REIMS analysis was performed using a forceps-shaped sampling probe connected to a power-controlled Valleylab Force EZ electrosurgical generator that was used as a RF power supply at a setting of 60W. Rapid heating of the microbial biomass results in the production of an aerosol which is directly sampled by a Thermo Scientific Exactive Mass Spectrometer

operated in negative ion mode over the mass range of m/z 150-2000 using a 1.5m long polymer tubing connected to the mass spectrometer inlet capillary. Determination of taxon-specific markers. Bacterial REIMS profiles were imported into Matlab environment where an ANOVA test followed by Tukey s honest significant difference test was performed to derive taxon-specific markers. For this, the spectral profiles of different groups of bacteria were compared to each other on all relevant taxonomical levels (species- up to kingdom-level) to determine whether certain types of signals could be assigned only to a certain group of bacteria. Fungi were included into the analysis as was the NCI60 cell line panel to cover the human lipidome. Desorption Electrospray Ionization Mass Spectrometry Imaging. In DESI, a pneumaticallyassisted electrospray is directed on the surface of a sample to allow for ambient surface sampling. DESI-MSI experiments were performed using an automated home-built DESI source mounted on a Thermo Scientific Exactive Mass Spectrometer. Mass spectra were acquired in negative ion mode over the mass range of m/z 200-1050. For imaging experiments, human colorectal tissue specimens (both healthy and cancerous) were cryosectioned to 10 m thickness and thaw-mounted on Superfrost glass slides. For DESI mass spectrometry imaging experiments, horizontal line scans were performed over the tissue surface and combined to form a two-dimensional spatially-resolved chemical map of the tissue section. For DESI experiments, methanol/water (95:5 v/v) was used as electrospray solvent at a flow rate of 1.5uL/min. Nitrogen was used as a nebulizing gas at a pressure of 7bar. The distance between DESI sprayer and sample was 1.5mm and the distance of inlet capillary and sprayer was set to 14mm. RESULTS This study was designed to determine the applicability of taxonomical markers and the proposed workflow to determine different types of bacteria present in a given sample. These samples can be composed of a mixture of different bacteria as in microbial communities or bacteria in a complex human matrix such as tissues. Taxon-specific markers can be found for a range of bacteria and on different taxonomical levels, however, there is not necessarily a specific marker available at every taxonomical level for a certain group of bacteria. The following selection of taxonomic markers could be established that showed specificity for certain groups of bacteria and that were absent in both human samples and fungal samples.

There are two different types of taxonomical markers, those that are continuously expressed under arbitrary culturing conditions and others that are produced from certain strains only or under certain conditions only and in variable amounts. Very specific conserved taxonomical markers include - Mycolic acids for bacteria belonging to the Corynebacterineae suborder such as Mycobacterium spp., Corynebacterium spp. and Rhodococcus spp.. From REIMS experiments and from literature it is known that the mycolic acid chain length is additionally very specific to the genus of bacteria within the Corynebacterineae suborder. It was further shown that mycolic acid patterns can be specific for certain species within a single genus. However, the REIMS dataset has to be further enlarged to validate species-specific mycolic acid patterns. The following mycolic acids have been detected from the corresponding genera: o Mycobacterium spp.: C77-C81 (even and odd numbered, 0-2 unsaturations) o Corynebacterium spp.: C28-C36 (even numbered, 0-2 unsaturations) o Nocardia spp.: C48-C56 (even numbered, 0-3 unsaturations) o Rhodococcus spp.: C28-C38 (even and odd numbered, 0-4 unsaturations) - A variety of sphingolipid species were found to be specific for members of the Bacteroidetes. These sphingolipids include oxidized ceramides species, phosphoethanolamine dihydroceramides and C15:0-substituted phosphoglycerol dihydroceramides and dihydroceramide. Among those sphingolipid species, a series of galactosylated sphingolipids was found to be specific for Bacteroides fragilis (Bacteroides fragilis alpha- Galactosylceramides) - Among bacteria, plasmalogens are highly specific for anaerobic bacteria such as Clostridium spp. and Fusobacterium spp.. This is due to the fact that aerobic bacteria lost the biochemical pathway required for plasmalogen synthesis. Humans however are able to synthesize plasmalogens (although via a different biochemical pathway from anaerobes) although these were generally found to have longer chain lengths than bacterial plasmalogens.

1. REIMS of microorganisms 2. DESI imaging of colorectal tissue samples Erbe irrigated bipolar forceps powered by Valleylab Force EZ electrosurgical power-controlled generator, operated at 60W in bipolar mode, 470kHz sinusoidal, negative ion mode, m/z 150-2000, R=50,000. Spray solvent: methanol/water (95:5) at 1.5 L/min, spray voltage 4.5kV, distance sprayer-sample/sprayersniffer/sniffer-sample: 1.5mm/14mm/0.1mm, negative ion mode, m/z 200-1000, R=100,000. Compiling large-scale database of bacterial spectral patterns Histologically assigned DESI imaging dataset Dataset comprising 555 bacterial (172 species, 71 genera) and 186 fungal strains (11 genera, 42 species), cultured under various conditions. Dataset consisting of 101 human colorectal tissue samples (48 cancerous, 53 healthy) from 43 different patients. Extracting taxon-specific markers Generating single ion images for markers determined to be of bacterial origin Anova test followed by Tukey s HSD test performed on different taxonomical levels. Taxonomical markers have to be produced under arbitrary culturing conditions (liquid/solid culturing medium, different media, different atmospheres). Generation of single ion images using MSiReader toolbox, 0.005Da bin size, linear interpolation (order 2), original ion intensities. Figure 1. Workflow used in presented study. A REIMS spectral database is generated and used to derive taxon-specific markers for bacteria. DESI imaging of tissue sections is performed and bacterial markers are visualised in DESI imaging datasets.

Other less conserved taxonomical markers that are indicative of a certain group of bacteria but might show very different production amounts include for instance lipopeptides that are produced specifically by certain Bacillus species such as surfactin for B. subtilis and lichenysin for B. licheniformis. Production of these two molecules also enables straightforward differentiation of these otherwise very closely related bacteria. A further example includes PQS-derived quorum-sensing molecules and mono- and di-rhamnolipid species found for Pseudomonas aeruginosa. Subsequently, to demonstrate the applicability of these taxonomical markers for the detection of bacteria in biological samples, we attempted to visualize the presence and distribution of bacteria in colorectal tissue specimens where bacteria are known to cover the mucosal membranes in the gut by generating single ion images for the taxonomical markers that were obtained in earlier steps. A variety of largely co-localized compounds were detected that could be attributed to the Bacteroidetes phylum as is displayed for an exemplary tissue specimen in Figure 2. The areas of strong bacterial presence in this cancerous tissue specimen could be correlated with necrotic tissue areas (see Figure 2) as determined by a histopathologist. The most intense bacterial presence was always found in necrotic tissue areas. A multitude of sphingolipid species could be detected in necrotic tissues whereas only the most intense bacterial peaks could be observed in the majority of non-necrotic samples. The molecules that are specific to Bacteroidetes fragilis could not be detected suggesting that the Bacteroidetes bacteria present do not contain a high amount of the opportunistic pathogen B. fragilis. Members of the Bacteroidetes phylum were reported in metagenomic studies to be accountable for up to 50% of the gut microbial community. A mass spectrum of the necrotic tissue and the surrounding cancer tissue is shown in Figure 3 and displays markedly different phospholipid compositions with a variety of sphingolipidderived taxonomic marker species clearly visible in the mass range of m/z 500-700.

a) DESI-MS image c) b) H&E image Figure 2. a) RGB DESI image displaying tissue morphology, b) corresponding H&E image, necrotic areas marked. c) Single ion images for homologous ceramides (top), phosphoethanolamine dihydroceramides (middle) and C15:0-substituted phosphoglycerol dihydroceramides (bottom). Figure 3. Full scan mass spectra for colorectal adenocarcinoma (bottom) and as obtained for necrotic area of same tissue section. Arrows indicate taxonomic markers. CONCLUSIONS This study demonstrates that molecular species differ significantly between microbial lipidomes and the human tissue lipidome. Based on a database of REIMS lipid profiles of

both microorganisms and human cell lines, taxon-specific markers were found for a variety of bacterial species on different taxonomic levels. These markers were shown to be absent in human lipidomes/metabolome and can thus be used to visualize the presence of bacteria in human samples such as shown for human colorectal tissues. It was further demonstrated that taxonomic markers derived by the REIMS technique can be used in conjunction with other mass spectrometric ionization techniques detecting lipid profiles such as DESI, which is more suitable to the direct analysis of mucosal sampling devices or mass spectrometry imaging. The presented approach can be extended to a wide variety of applications as the characterization of microbial communities during endoscopic interventions using REIMS, and for the detection of microbes in human sterile and non-sterile biofluid samples to facilitate appropriate antibiotic treatment.